Target Price | $1.00 |
Price | $0.97 |
Potential |
3.41%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Kronos Bio Inc price target 2025.
The average Kronos Bio Inc target price is $1.00.
This is
3.41%
register free of charge
|
|
A rating was issued by 2 analysts: 0 Analysts recommend Kronos Bio Inc to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Kronos Bio Inc stock has an average upside potential 2025 of
3.41%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 6.29 | 10.00 |
58.98% | ||
Net Margin | -1,870.64% | -784.42% |
58.07% |
1 Analyst has issued a sales forecast Kronos Bio Inc 2024 . The average Kronos Bio Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Kronos Bio Inc 2024 . The average Kronos Bio Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.95 | -1.30 |
17.72% | 33.33% | |
P/E | negative | |
EV/Sales | negative |
1 Analysts have issued a Kronos Bio Inc forecast for earnings per share. The average Kronos Bio Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Kronos Bio Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.